Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.49 +0.03 (1.22%)
Previous Close $2.46    52 Week High $7.79 
Open $2.47    52 Week Low $4.32 
Day High $2.49    P/E N/A 
Day Low $2.43    EPS $-0.36 
Volume 77,537